INDV Indivior Pharmaceuticals

• $312K bought by 7 insiders
• None no sales outside a trading plan
• $2.8M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Woodrow D Anderson Chief Accounting Officer
   Buy
   $54K 1,500 shares at $35.69 +5.7% to stake
   Traded Aug 27 Filed Aug 27
   ↗
3. Woodrow D Anderson Chief Accounting Officer
   Buy
   $54K 1,500 shares at $36.28 +6.1% to stake
   Traded Aug 5 Filed Aug 5
   ↗
4. Christian Heidbreder Chief Scientific Officer
   Planned sale
   $765K 18,586 shares at $41.14 8.2% of stake
   Traded Jul 10 Filed Jul 13
   ↗
5. Christian Heidbreder Chief Scientific Officer
   Planned sale
   $707K 18,586 shares at $38.06 7.5% of stake
   Traded Jun 11 Filed Jun 12
   ↗
6. Ryan Preblick CFO
   Planned sale
   $1.4M 36,000 shares at $37.70 11% of stake
   Traded Jun 8 Filed Jun 10
   ↗
7. Barbara Ryan Director
   Buy
   $249 8 shares at $31.09 +0.1% to stake
   Traded Mar 13 Filed Mar 13
   ↗
8. Barbara Ryan Director
   Buy
   $1,009 31 shares at $32.56 +0.5% to stake
   Traded Mar 9 Filed Mar 11
   ↗
9. Stuart A Kingsley Director
   Buy
   $30K 940 shares at $31.87 +20% to stake
   Traded Mar 6 Filed Mar 11
   ↗
10. Keith Humphreys Director
    Buy
    $27K 775 shares at $35.39 +15% to stake
    Traded Jan 5 Filed Jan 7
    ↗
11. David E. Wheadon Director
    Buy
    $63K 1,771 shares at $35.39 +14% to stake
    Traded Jan 5 Filed Jan 7
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 stock grants, 8 share withholdings for taxes, and 7 option exercises.